To investigate the role of GCN5 in pressure overload-induced cardiac hypertrophy in vivo, GCN5 was overexpressed in mice using the AAV9 system containing null and GCN5 via tail vein injection. The gene discussed is KAT2A; the disease is cardiac hypertrophy.